Physician profile
David A Pula
NPI 1801867684
$13,322.39
in general payments reported to CMS, 2019-2025
16 companies · $735 in 2025
The $735 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,751 · 2020: $919 · 2021: $976 · 2022: $2,074 · 2023: $1,995 · 2024: $1,871 · 2025: $735.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,544 · Travel and Lodging: $2,057.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,543.91 |
| Travel and Lodging | $2,057.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $4,773.51 | 2019-2025 | |
| Stryker Corporation | $3,805.08 | 2019-2025 | Mako, Triathlon, Insignia |
| Prodigy Surgical Distribution, INC. | $2,978.72 | 2020-2025 | |
| Depuy Synthes Sales INC. | $731.88 | 2021-2023 | |
| Smith+Nephew, INC. | $292.89 | 2019-2023 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Spatial Frame, Firstpass |
| Innovation Technologies INC | $223.27 | 2022 | |
| Davol INC. | $129.97 | 2023 | |
| Abbott Laboratories | $114.07 | 2024 | Octrode |
| Medical Device Business Services, INC. | $104.34 | 2023 | Attune |
| Biocomposites INC | $38.04 | 2025 | Stimulan |
| Amgen INC. | $23.99 | 2021 | |
| Pacira Therapeutics, INC. | $23.04 | 2019 | |
| Solventum Corporation | $21.98 | 2024 | Prevena |
| Baxter Healthcare | $21.70 | 2024 | Perclot |
| Horizon Therapeutics Plc | $20.62 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $19.29 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Pula listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.